Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
B. Balcan (Istanbul, Turkey), E. Thunström (Gothenburg, Sweden), Y. Peker (Istanbul, Turkey). Depression and response to CPAP treatment in coronary artery disease patients with sleepy vs nonsleepy obstructive slee apnoea. 4966

Member's Comments

No comment yet.

Related content which might interest you: Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017 Year: 2017 Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021 CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence Year: 2020 Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Effect of positive airway pressure on diastolic function in coronary artery disease patients with non-sleepy obstructive sleep apnea Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea Year: 2016 Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA). Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017 CPAP does not reduce inflammatory biomarkers in coronary artery disease patients with nonsleepy obstructive sleep apnoea: a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Association between plasma leptin levels and obstructive sleep apnoea in non-obese patients with coronary artery disease and response to CPAP treatment Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 Association between coronary artery disease (CAD) and heart failure and age in obstructive sleep apnoea (OSA) patients Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014 Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD) Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease Source: International Congress 2017 – CPAP therapy Year: 2017 Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Predictors of obstructive sleep apnoea in patients admitted for acute coronary syndrome Source: Eur Respir J , 49 (3) 1600550; DOI: 10.1183/13993003.00550-2016 Year: 2017 The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016